These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11973420)

  • 1. Intravenous adrenomedullin in myocardial function and energy metabolism in patients after myocardial infarction.
    Nagaya N; Goto Y; Satoh T; Sumida H; Kojima S; Miyatake K; Kangawa K
    J Cardiovasc Pharmacol; 2002 May; 39(5):754-60. PubMed ID: 11973420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial natriuretic peptide attenuates pacing-induced myocardial ischemia during general anesthesia in patients with coronary artery disease.
    Valsson F; Lundin S; Kirnö K; Hedner T; Houltz E; Saito Y; Ricksten SE
    Anesth Analg; 1999 Feb; 88(2):279-85. PubMed ID: 9972741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction.
    Richards AM; Nicholls MG; Yandle TG; Frampton C; Espiner EA; Turner JG; Buttimore RC; Lainchbury JG; Elliott JM; Ikram H; Crozier IG; Smyth DW
    Circulation; 1998 May; 97(19):1921-9. PubMed ID: 9609085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of human atrial natriuretic peptide on myocardial performance and energetics in heart failure due to previous myocardial infarction.
    Ozawa T; Shinke T; Shite J; Takaoka H; Inoue N; Matsumoto H; Watanabe S; Yoshikawa R; Otake H; Matsumoto D; Ogasawara D; Yokoyama M; Hirata K
    J Cardiol; 2015 Sep; 66(3):232-8. PubMed ID: 25722046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.
    Omland T; Aakvaag A; Bonarjee VV; Caidahl K; Lie RT; Nilsen DW; Sundsfjord JA; Dickstein K
    Circulation; 1996 Jun; 93(11):1963-9. PubMed ID: 8640969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of atrial natriuretic peptide on left ventricular function in hypertension.
    Semigran MJ; Aroney CN; Herrmann HC; Dec GW; Boucher CA; Fifer MA
    Hypertension; 1994 Sep; 24(3):271-9. PubMed ID: 8082932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial circulatory and metabolic effects of atrial natriuretic peptide after coronary artery bypass grafting.
    Valsson F; Lundin S; Kirnö K; Hedner T; Saito Y; Ricksten SE
    Anesth Analg; 1996 Nov; 83(5):928-34. PubMed ID: 8895265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of therapeutic doses of human atrial natriuretic peptide on load and myocardial performance in patients with congestive heart failure.
    Mizuno O; Onishi K; Dohi K; Motoyasu M; Okinaka T; Ito M; Isaka N; Nakano T
    Am J Cardiol; 2001 Oct; 88(8):863-6. PubMed ID: 11676948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of human atrial natriuretic peptide on cardiac function and hemodynamics in patients with high plasma BNP levels.
    Nakajima K; Onishi K; Dohi K; Tanabe M; Kurita T; Yamanaka T; Ito M; Isaka N; Nobori T; Nakano T
    Int J Cardiol; 2005 Oct; 104(3):332-7. PubMed ID: 16186065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effects of adrenomedullin on left ventricular remodeling after myocardial infarction in rats.
    Nakamura R; Kato J; Kitamura K; Onitsuka H; Imamura T; Marutsuka K; Asada Y; Kangawa K; Eto T
    Cardiovasc Res; 2002 Dec; 56(3):373-80. PubMed ID: 12445878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenomedullin-epinephrine cotreatment enhances cardiac output and left ventricular function by energetically neutral mechanisms.
    Stenberg TA; Kildal AB; How OJ; Myrmel T
    Am J Physiol Heart Circ Physiol; 2012 Apr; 302(8):H1584-90. PubMed ID: 22307666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of intravenous atrial natriuretic peptide on cardiac sympathetic nerve activity and left ventricular remodeling in patients with first anterior acute myocardial infarction.
    Kasama S; Toyama T; Hatori T; Sumino H; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    J Am Coll Cardiol; 2007 Feb; 49(6):667-74. PubMed ID: 17291931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials.
    Kitakaze M; Asakura M; Kim J; Shintani Y; Asanuma H; Hamasaki T; Seguchi O; Myoishi M; Minamino T; Ohara T; Nagai Y; Nanto S; Watanabe K; Fukuzawa S; Hirayama A; Nakamura N; Kimura K; Fujii K; Ishihara M; Saito Y; Tomoike H; Kitamura S;
    Lancet; 2007 Oct; 370(9597):1483-93. PubMed ID: 17964349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study.
    Woo JS; Kim W; Ha SJ; Kim JB; Kim SJ; Kim WS; Seon HJ; Kim KS
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2252-60. PubMed ID: 23868944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of intravenous atrial natriuretic peptide on cardiac sympathetic nerve activity in patients with decompensated congestive heart failure.
    Kasama S; Toyama T; Kumakura H; Takayama Y; Ishikawa T; Ichikawa S; Suzuki T; Kurabayashi M
    J Nucl Med; 2004 Jul; 45(7):1108-13. PubMed ID: 15235055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of shenqifuxin oral liquid on the plasma kaliuretic peptide, the myocardial contractility and relaxation of left ventricle and the left ventricular remodeling in experimental rats with heart failure].
    Ma L; Lei Y; Xue Q; Wang SW; Yang DY; Lu ZZ
    Zhongguo Zhong Yao Za Zhi; 2003 Jul; 28(7):656-60. PubMed ID: 15139115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The first clinical pilot study of intravenous adrenomedullin administration in patients with acute myocardial infarction.
    Kataoka Y; Miyazaki S; Yasuda S; Nagaya N; Noguchi T; Yamada N; Morii I; Kawamura A; Doi K; Miyatake K; Tomoike H; Kangawa K
    J Cardiovasc Pharmacol; 2010 Oct; 56(4):413-9. PubMed ID: 20930593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levosimendan enhances left ventricular systolic and diastolic function in conscious dogs with pacing-induced cardiomyopathy.
    Pagel PS; McGough MF; Hettrick DA; Lowe D; Tessmer JP; Jamali IN; Warltier DC
    J Cardiovasc Pharmacol; 1997 May; 29(5):563-73. PubMed ID: 9213196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxygen-saving effect of a new cardiotonic agent, MCI-154, in diseased human hearts.
    Mori M; Takeuchi M; Takaoka H; Hata K; Hayashi Y; Yamakawa H; Yokoyama M
    J Am Coll Cardiol; 1997 Mar; 29(3):613-22. PubMed ID: 9060901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant bovine growth hormone-induced reduction of atrial natriuretic peptide is associated with improved left ventricular contractility and reverse remodeling in cardiomyopathic UM-X7.1 hamsters with congestive heart failure.
    Mulumba M; Céméus C; Dumont L; du Souich P; Ong H; Marleau S
    Growth Horm IGF Res; 2007 Apr; 17(2):96-103. PubMed ID: 17280860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.